Jian-wei W. Xie - Publications

Beyond TNM staging: validation of a CT-derived nutritional-inflammatory composite model (RFMmSIS) for prognostication in resectable gastric cancer.

Journal: BMC cancer

Published: May 01, 2026

Optimizing patient selection for neoadjuvant immunotherapy in gastric cancer via pre-treatment imaging analysis.

Journal: Frontiers in immunology

Published: April 07, 2026

CT assessment of body composition and liver fat fraction predicts prognosis in gastric cancer.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 16, 2026

Immune-inflammatory-fibrinogen score as a novel prognostic biomarker in patients with gastric cancer undergoing radical gastrectomy: a multicenter study.

Journal: World journal of surgical oncology

Published: February 07, 2026

Retraction Note: CDK5RAP3 as tumour suppressor negatively regulates self-renewal and invasion and is regulated by ERK1/2 signalling in human gastric cancer.

Journal: British journal of cancer

Published: January 20, 2026

Integrating multi-omics data for enhanced prognosis prediction in gastric cancer post-neoadjuvant therapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 03, 2026

When adipose meets inflammation: a novel adiposity-inflammation signature predicts prognosis and chemotherapy benefit in locally advanced gastric cancer.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 28, 2025

Post-surgical lymph node status guides perioperative chemotherapy completion for locally advanced gastric cancer.

Journal: Surgical endoscopy

Published: October 21, 2025

Recurrence outcome and prediction model of patients with gastric cancer underwent laparoscopic-assisted total gastrectomy: A retrospective study.

Journal: Surgery

Published: July 09, 2025

Perioperative camrelizumab and apatinib combined with chemotherapy for locally advanced gastric cancer in China: three-year survival outcomes of phase 2 randomized controlled trial.

Journal: EClinicalMedicine

Published: June 24, 2025

Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: June 13, 2025

Selection and research advances of intraperitoneal drug treatment for colorectal peritoneal metastasis

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Published: May 22, 2025